| 1 |
33289342 | Sulfasalazine synergistically enhances the inhibitory effects of imatinib against hepatocellular carcinoma (HCC) cells by targeting NFκB, BCR/ABL, and PI3K/AKT signaling pathway-related proteins. | 2021 Mar |
1 |
| 2 |
33527482 | Expression of inducible NOS is indispensable for the antiproliferative and proapoptotic effect of imatinib in BCR-ABL positive cells. | 2021 Nov |
1 |
| 3 |
29945498 | Expression analysis of Akirin-2, NFκB-p65 and β-catenin proteins in imatinib resistance of chronic myeloid leukemia. | 2018 Dec |
3 |
| 4 |
26874514 | Use of deferasirox, an iron chelator, to overcome imatinib resistance of chronic myeloid leukemia cells. | 2016 Mar |
2 |
| 5 |
23383209 | Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1. | 2013 |
4 |
| 6 |
23892407 | Doxorubicin induces atypical NF-κB activation through c-Abl kinase activity in breast cancer cells. | 2013 Oct |
1 |
| 7 |
24125838 | CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment. | 2013 Nov |
3 |
| 8 |
21935477 | Effects of Imatinib Mesylate (Gleevec) on human islet NF-kappaB activation and chemokine production in vitro. | 2011 |
3 |
| 9 |
18977528 | Imatinib resistance in multidrug-resistant K562 human leukemic cells. | 2009 May |
1 |
| 10 |
19378338 | NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants. | 2009 Jul 15 |
3 |
| 11 |
18245668 | IkappaB kinase beta inhibition induces cell death in Imatinib-resistant and T315I Dasatinib-resistant BCR-ABL+ cells. | 2008 Feb |
3 |
| 12 |
18619726 | Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigens. | 2008 Oct |
2 |
| 13 |
16174751 | The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation. | 2005 Sep 20 |
1 |
| 14 |
10979973 | CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. | 2000 Sep 15 |
1 |